As an undergraduate at North Carolina State University, I began to appreciate the pragmatic perspective and mathematical methods of research in biomedical engineering, and I sought to apply this empirical approach to medicine. This lead me to pursue an MD-PhD dual-degree with the University of North Carolina in hopes of leading medical researchers in facilitating the translation of new treatments and technologies into the clinic. I am particularly interested in studying neurophysiology through computational modeling, specifically with regard to neuroplasticity in both a single neuron as well as across neuronal circuits. Gaining a basic mechanistic understanding of neuronal regulation has great implications for understanding and treating various neurological disorders and pathologies. The ideal solution to any illness, especially neurodegenerative diseases, involves input from all applicable fields, including basic science, clinical science, epidemiology, sociology, and psychology, among others. The Gates Cambridge community promotes collaboration across this wide range of disciplines, and I hope to apply my engineering background and clinical experiences to my graduate work and many future projects. With careful consideration of all these viewpoints, we can achieve our ultimate goal of providing the best possible patient care.
North Carolina State University
The University of North Carolina, Chapel Hill
I'm the Founder and General Partner of Air Street Capital, a venture capital firm investing in AI-first technology and life science companies.
Computer-aided drug discovery is - potentially - able to shorten the development phase of new drugs and at the same time it reduces the number of animals used for experiments. Being on the borderline between computer algorithms and chemistry it is both exciting and "sensible" work to do and I am looking forward to having an enjoyable and fruitful time in the field.
I am an assistant professor in the Department of Geography and School of Modern Languages & Cultures (China Studies Programme) at the University of Hong Kong. Through fieldwork and remote sensing, I research the politics of infrastructure development in frontier spaces, namely the Arctic and areas included within China's Belt and Road Initiative. I also run a blog, Cryopolitics, which provides Arctic news, analysis, and travelogues.
Technological growth optimizing human experience while reducing information access barriers will ultimately lead to a more productive and satisfied world. Not limited to this technological interest, as former Chair of the Gates Scholar Council I have also explored published tenets about cross-cultural organizational behavior and politics, in the hope that creative solutions might emerge which reduce the usual bureaucratic boundaries which preclude the emergence of these technologies.
I grew up in Brisbane, Australia, surrounded by incredible areas of biodiversity, and was always asking questions about the animals around me. While working at RSPCA Queensland, I learned that as well as being critical parts of complex ecosystems, animals are individuals with unique personalities that influence how they move through the world. In my Honours study at the University of Queensland, I investigated the movement ecology and thermal physiology of salt water crocodiles, analysing over 9 million data points in R. It was here that I became fascinated by the insight we can obtain from remote monitoring of wildlife, and the challenges and benefits of analysing large, long term data sets. During my PhD in Zoology, I will investigate the way that antarctic seabirds use ocean habitat, to better understand polar ecology, to mitigate bycatch, and ultimately conserve these species. In addition to my academic interests, I am passionate about the value of outreach and education in the sciences. I believe that if we can better explain the excitement of scientific research to the wider community, we have a better chance of successfully implementing the policy changes needed to save endangered species and mitigate the effects of climate change.
University of Queensland
Having graduated from the medical school in Padua I am currently attending my last year of anaesthesia and intensive care residency school at the University of Milan. I see research to be an integral part of my development as a clinician. For this reason I undertook a research placement at the Brain Physics Lab at Cambridge University, where I assumed duties as a local coordinator of the COGiTATE clinical trial. I got involved in several analytical projects on cerebral blood flow autoregulation (CA) monitoring and intracranial pressure waveform analysis for which I have been awarded with a scholarship by CENTER-TBI. A need for personalized medicine is increasingly acknowledged. In particular, individualized management of traumatic brain injury (TBI) based on continuous monitoring of CA has attracted a lot of attention in the neuro-critical care community. My PhD project will aim to improve measurement, understanding and visualisation of the dynamic profile of CA at the bedside, integrated with assessment of its determinants, ultimately facilitating better informed recommendations for individualised management of TBI potentially leading to improvement of outcome in this group of patients.
Universita Degli Studi di Milano Anestesia e rianimazione 2020
University of Padova Medicina e Chirurgia 2013
I work as a management consultant with a focus on healthcare, mostly in diabetes and oncology. My work uses analytics and healthcare data from insurers, patients, and doctors ("real world data") to improve clients' marketing and sales strategy and operations.
After growing up in San Antonio, Texas, I undertook my undergraduate studies at Princeton University, where I am completing a degree in computer science. During my studies at Princeton, I discovered computational biology, and began working under Professor Mona Singh. My independent work revolves around constructing a computational pipeline capable of leveraging cancer genomic and transcriptional data to identify metabolites closely associated with breast cancer. These cancer-associated metabolites, or "driver metabolites," could prove key for understanding the metabolic alterations that form a hallmark of cancer development. At the Cancer Research UK Cambridge Institute, I aim to continue my exploration of cancer metabolism and cancer evolution. In particular, I would like to explore structural and network-based models for understanding metabolic pathways important to cancer. These two areas should greatly refine my pipeline, improving its ability to uncover driver metabolites. It is my hope that augmenting our understanding of cancer metabolism and driver metabolites will open up new venues for cancer drug development and treatment.
I am a Group Leader and Lecturer in Synthetic Biology and at the ISMB, a joint institute between University College London and Birkbeck. My aim is to establish a driven multi-disciplinary team, fostering innovation, collaboration and excellence, to probe the limits of our understanding of biological systems through synthetic biology. Previously, I worked at the MRC Laboratory of Molecular Biology in Cambridge, first as a Career Development Fellow (2006-2009) and later promoted to Investigator Scientist (2009-2013). Throughout that period, I worked with Dr. Phillip Holliger on the directed evolution of DNA polymerases and synthetic nucleic acids. I did my PhD in the Biochemistry Department at the University of Cambridge working with Professor David Ellar on the molecular evolution of Yersinia pestis (2001 – 2006) following my undergraduate training at the University of Cambridge in Natural Sciences (Biochemistry; 1997 – 2001).
Oncology research has always been a passion of mine. Throughout my undergraduate study at Penn State, I made a point of exploring the full spectrum of biomedical research, from basic gene regulation work to clinical studies of chemotherapeutic toxicity. While I began in wet-bench basic and translational science, intending to work as close to the fundamental mechanisms of cancer as possible, I ultimately found that I preferred the research methodology and the universal applicability of epidemiology and biostatistics. To me, cancer risk prediction and risk stratification is the ideal fusion of genetics, clinical significance, and statistical methodology, allowing me to utilize my broad skillset to assist patients through cancer prevention, when interventions are by far the most effective. My ultimate goal is to become a physician-scientist with a specialty in oncology and a research focus on cancer epidemiology. To me, a PhD in Cambridge’s Department of Public Health and Primary Care is the perfect complement to my medical ambitions, allowing me to integrate my research directly into the clinic and help inform patient treatment around the world.
University of Cambridge Epidemiology 2019
Pennsylvania State University Pre-Medicine 2018
My name is Rebecca Berrens and I am a molecular biologist studying the role of transposable elements in early mammalian development. I did my undergraduate at the University of Heidelberg. I did my Bachelor thesis at EMBL in the lab of Matthias Hentze and studied miRNAs and was fascinated by the function of these small RNAs in the cell. I then did my Master's at CSHL in Greg Hannon's lab and learned the first time that in our genome there are transposable elements which can jump in the genome. During my PhD in Wolf Reiks lab at the Babraham institute in Cambridge I studied how the genome controls transposable elements by epigenetic modifications in early development. Now as a postdoc at CRUK-CI I am studying how transposable element expression controls gene expression during cell fate decision. This study will help to unravel the intricate relationship between the selfish jumping genes and our genome.
After leaving Cambridge, I went to Washington DC to work at the Council of Economic Advisers at the White House, where I worked as a staff economist, and then economist.
Before coming to Cambridge I studied psychology and criminology in Leiden and Amsterdam. For my PhD I investigated mechanisms explaining the intergenerational transmission of violent and criminal behaviour. Why do children of criminal/aggressive parents have a higher risk of showing similar behaviour? I contrasted several explanations for this intergenerational continuity such as social learning, official bias against certain families, and the transmission of risk factors. I investigated this in England as well as in the Netherlands. By doing this I hope to contribute to knowledge about the development of aggression and criminal behaviour, which can help to design interventions against such behaviour. I am fascinated by human development of which these types of behaviour are just one part. During my post-doc at UC Berkeley I continued this line of research and also looked at the opposite: how does children's problem behavior impact on parenting practices? I now work as part of the Trust and Safety Team at Uber in SF to make sure Uber is the safest place in the world.
I am interested in understanding the architecture of the brain and how it contributes to making us the way we are. I believe that increasingly, discourses in education will be based on a science of learning rooted in our understanding of brain function. My goal is to establish a productive laboratory to pursue research in the neural mechanisms of higher cognition. I hope to build bridges with the education and EdTech community and fulfil the promise that neuroscience holds for education.
University of Edinburgh M.Sc. Neuroscience 2008
National Centre for Biological Science, India Biology (no degree) 2004
St. Xavier's College, Gujarat University, India B.Sc. Biochemistry 2003
Passionate about delivering quality health care to all, I came to Stanford with the intention of taking up a career in health care . Pursuing a bachelor’s in biology, a master’s in biomedical informatics, and genomics research equipped me adequately to understand the role of genome mutations in disease processes. At the McDonnell Genome Institute at Washington University, I searched sequencing and expression data for patterns in tumor suppressors and oncogenes that caused cancer. At Stanford, I studied translational allelic-specific expression in human lymphoblastoid cells. The complexity of our genome fascinated me, and I garnered a desire to understand ways in which genome could be modified disease processes. With increasing availability of sequencing data, it is important to gain the skills to analyze and interpret this data meaningfully for a future of genetics-driven, preventative, personalized medicine. Thus at Cambridge, I will pursue a Masters of Philosophy in Genomic Medicine exploring ways to incorporate sequencing data and technologies directly into patient care delivery. After Cambridge, I plan to do an MD/Ph.D, which will enable me to deliver health care in innovative ways to my local community and bring personalized medicine to bedside globally. Outside academics, I am the founder of Stanford Music and Medicine, an organization that recruits Stanford students to use music as a form of therapy for nursing home residents. I also work for a non-profit that develops arts-based science supplemental lesson plans for middle school students in East Palo Alto. In my free time, I love singing in the shower, hiking, and horror films.